33 Recruiting Trials

Clinical Trials
for Kidney Disease in Massachusetts

33 clinical trials for Kidney Disease are currently recruiting participants at study sites in Massachusetts. Study-related care is provided at no cost.

33
Recruiting trials
28
Study sites
9
Cities
14
Industry-sponsored
8
Phase 2
8
Phase 3

Kidney Disease clinical trials in Massachusetts: what to expect

Kidney disease trials are mostly for chronic kidney disease that is slowly getting worse, including kidney disease caused by diabetes. They test medicines meant to slow the decline in kidney function and protect the heart, usually on top of the standard blood pressure and diabetes treatments. Specific kidney diseases such as IgA nephropathy, FSGS and polycystic kidney disease now have many trials of their own, and separate studies enroll people on dialysis or living with a transplant.

In Massachusetts, recruiting kidney disease studies are concentrated in Boston, Worcester, New Bedford and Braintree, with sites in 5 other cities. 14 of the 33 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who kidney disease trials usually look for

Trials describe kidney disease by two numbers: the filtration rate (eGFR) from a blood test and the amount of protein in the urine. Most enroll an eGFR between about 20 and 75 and a urine protein level above a cut-off, both measured at screening. Nearly all ask that you have taken a stable dose of a blood-pressure medicine of the ACE inhibitor or ARB type for three months, and many allow or require an SGLT2 inhibitor. IgA nephropathy and FSGS trials need a past kidney biopsy. Common exclusions are a transplant, dialysis and uncontrolled blood pressure.

What taking part involves

Screening includes blood and urine tests, sometimes a 24-hour urine collection, and a review of your records. Trials then run one to three years with visits every four to twelve weeks for labs and blood pressure, taking a study pill or injection added to your usual medicines; placebo arms are common and an extension often follows. Your nephrologist keeps managing your care. Study medicine and tests are free and visits are usually paid.

Questions worth asking the study team

Which stage the trial enrolls and whether you fit it; whether any of your medicines change; how often labs are needed; the chance of placebo; and whether you will be told your own kidney results during the study.

Showing 20 of 33 recruiting Kidney Disease trials in Massachusetts

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
PHASE3 Phoenix, Arizona +4 sites NCT05457283
This trial is looking for children and young adults aged 1 to 18 who have chronic kidney disease and proteinuria. Participants will take a treatment called finerenone alongside their current heart medicine for about 18 months.
Recruiting
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
PHASE3 Huntsville, Alabama +4 sites NCT07753993
This trial is looking for adults with chronic kidney disease to see how well elecoglipron works compared to a placebo. Participants must be on certain medications for their condition before joining the study.
Recruiting
The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease
N/A Boston, Massachusetts NCT07222683
This trial is looking for people who are candidates for a kidney transplant. Participants will have their heart health measured before and after the transplant to see how it affects their condition.
Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
PHASE2 Decatur, Alabama +4 sites NCT05485961
This trial is looking for adults with end stage kidney disease who are undergoing dialysis and have systemic inflammation. Participants will receive a study medication or a placebo to see how it affects heart health.
Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
PHASE3 Fairhope, Alabama +4 sites NCT06742723
This trial is looking for adults with chronic kidney disease and high blood pressure. If you join, you will take medications to see how they affect your kidney health and heart-related risks.
Recruiting
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
PHASE2 Alabaster, Alabama +4 sites NCT05312879
This trial is looking for adults and children with a specific type of kidney disease caused by genetics. Participants will receive the drug VX-147 to assess its effectiveness and safety.
Recruiting
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
PHASE2 Birmingham, Alabama +4 sites NCT06902558
This trial is looking for adults with a specific type of kidney disease. Participants will receive either the study drug or a placebo every 4 weeks for 92 weeks and will attend regular check-ups.
Recruiting
Bempedoic Acid Therapy for Polycystic Kidney Disease
PHASE2 Boston, Massachusetts +2 sites NCT07282821
This trial is looking for adults with autosomal dominant polycystic kidney disease (ADPKD) to test a new treatment. Participants will take bempedoic acid, which may help improve kidney function without the side effects of other treatments.
Recruiting
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
PHASE2 Alabaster, Alabama +4 sites NCT06824987
This trial is looking for adults of African descent with a specific type of kidney disease. Participants will take the drug AZD2373 and attend check-ups to see how well the treatment works and if it is safe.
Recruiting
Symptom Monitoring With Supported Feedback in Advanced Chronic Kidney Disease
NA Boston, Massachusetts NCT07186218
This trial is looking for adults with advanced chronic kidney disease (CKD) to participate in regular symptom reporting with feedback from their doctors. Participants will help improve understanding and treatment of their symptoms.
Recruiting
A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
N/A Boston, Massachusetts +4 sites NCT07006831
This trial is looking for kidney transplant patients to provide blood samples and information. The goal is to help develop a test that checks how well the transplanted kidney is functioning.
Recruiting
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
PHASE3 Long Beach, California +4 sites NCT05931276
This trial is looking for patients on hemodialysis who take certain beta blockers. Participants will receive either metoprolol or carvedilol to see how these medications affect heart health.
Recruiting
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
NA La Jolla, California +4 sites NCT04634916
This trial is looking for adults with end-stage kidney disease who need dialysis. Participants will undergo a procedure to create a connection for dialysis using the BD® WavelinQ™ EndoAVF System.
Recruiting
Incremental Hemodialysis: The TwoPlus Trial
NA Boston, Massachusetts +4 sites NCT05828823
This trial is looking for adults with kidney problems who need dialysis. Participants will either start a new type of dialysis called incremental hemodialysis or a traditional one. The trial will follow them for about two years to compare the outcomes.
Recruiting
Symptom Monitoring in Hemodialysis
NA Waltham, Massachusetts NCT05738330
This trial is looking for adults who are receiving hemodialysis and can speak English or Spanish. Participants will report their symptoms using a specific system for a year while receiving support from clinicians.
Recruiting
Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
PHASE2 Boston, Massachusetts NCT04500665
This trial is looking for adults with chronic kidney disease to see if colchicine is effective and safe. Participants will need to follow the study protocol and provide written consent.
Recruiting
Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
NA Boston, Massachusetts +4 sites NCT05465044
This trial is looking for Veterans who have kidney disease and need to start dialysis. Participants may be assigned to receive dialysis less often or the usual frequency, and will be monitored over the year.
Recruiting
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
NA Bullhead City, Arizona +4 sites NCT06001827
This trial is looking for adults with chronic kidney disease who need a new arteriovenous fistula for dialysis. Participants will receive a special wrap during the procedure and will follow up with the study team for 36 months.
Recruiting
NAD Augmentation in Diabetes Kidney Disease
PHASE2 Boston, Massachusetts NCT05759468
This trial is looking for adults with type 2 diabetes and kidney issues. Participants will take either NMN or a placebo for a study on kidney health.
Recruiting

Where the Kidney Disease studies are in Massachusetts

  • Brigham and Women's Hospital, Boston9 trials
  • Massachusetts General Hospital, Boston4 trials
  • Research Site, Boston3 trials
  • Research Site, New Bedford3 trials
  • Tufts Medical Center, Boston3 trials
  • Beth Israel Deaconess Medical Center, Boston2 trials

Counts are recruiting studies listing at least one site in Massachusetts, from ClinicalTrials.gov, refreshed every two days.

Kidney Disease clinical trials in Massachusetts: common questions

How many Kidney Disease clinical trials are recruiting in Massachusetts?
TrialFinder currently lists 33 recruiting Kidney Disease clinical trials with study sites in Massachusetts. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Kidney Disease clinical trials located in Massachusetts?
Study sites for the Kidney Disease trials listed on this page include Boston, Waltham. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Kidney Disease clinical trial in Massachusetts?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Kidney Disease trials in Massachusetts also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Kidney Disease clinical trial in Massachusetts?
Each study sets its own criteria based on age, Kidney Disease diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
What stage of kidney disease do trials look for?
Trials state an eGFR range and a urine protein threshold rather than a stage name; most cover stages 2 to 4. People on dialysis or with a transplant have separate trials written for them.
Do I need a kidney biopsy to join?
Trials for IgA nephropathy, FSGS and lupus nephritis require a past biopsy confirming the diagnosis. Trials for diabetic or general chronic kidney disease do not.
Will I keep my current kidney and blood pressure medicines?
Yes. Kidney trials add the study treatment to a stable regimen, usually including an ACE inhibitor or ARB, and your own nephrologist continues to manage them.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Kidney Disease trials near you in Massachusetts.

Get Matched — Free
No insurance required

Kidney disease trials evaluate SGLT2 inhibitors, dialysis protocols, renal transplant regimens, and supportive-care strategies for chronic and acute kidney disease.

All Kidney Disease trials →